Works matching IS 23661070 AND DT 2021 AND VI 9 AND IP 2
Results: 25
Implementing a Standardized Care Pathway Integrating Oncology, Palliative Care and Community Care in a Rural Region of Mid-Norway.
- Published in:
- Oncology & Therapy, 2021, v. 9, n. 2, p. 671, doi. 10.1007/s40487-021-00176-y
- By:
- Publication type:
- Article
Healthcare Costs Incurred by Patients with Multiple Myeloma Following Triple Class Exposure (TCE) in the US.
- Published in:
- Oncology & Therapy, 2021, v. 9, n. 2, p. 659, doi. 10.1007/s40487-021-00175-z
- By:
- Publication type:
- Article
<sup>18</sup>F-FDG-PET/CT as an imaging biomarker for regorafenib efficacy in metastatic colorectal cancer (JACCRO CC-12).
- Published in:
- Oncology & Therapy, 2021, v. 9, n. 2, p. 635, doi. 10.1007/s40487-021-00173-1
- By:
- Publication type:
- Article
Differential Levels of mRNAs in Normal B Lymphocytes, Monoclonal B Lymphocytosis and Chronic Lymphocytic Leukemia Cells from the Same Family Identify Susceptibility Genes.
- Published in:
- Oncology & Therapy, 2021, v. 9, n. 2, p. 621, doi. 10.1007/s40487-021-00172-2
- By:
- Publication type:
- Article
Response to PD-1-Based Immunotherapy for Non-Small Cell Lung Cancer Altered by Gut Microbiota.
- Published in:
- Oncology & Therapy, 2021, v. 9, n. 2, p. 647, doi. 10.1007/s40487-021-00171-3
- By:
- Publication type:
- Article
Does Breast Cancer Surgery Impact Functional Status and Independence in Older Patients? A Narrative Review.
- Published in:
- Oncology & Therapy, 2021, v. 9, n. 2, p. 373, doi. 10.1007/s40487-021-00170-4
- By:
- Publication type:
- Article
A Cost Impact Analysis of clonoSEQ<sup>®</sup> as a Valid and CE-Certified Minimal Residual Disease (MRD) Diagnostic Compared to No MRD Testing in Multiple Myeloma in Germany.
- Published in:
- Oncology & Therapy, 2021, v. 9, n. 2, p. 607, doi. 10.1007/s40487-021-00169-x
- By:
- Publication type:
- Article
Chemotherapy-Induced Peripheral Neuropathy: Epidemiology, Pathomechanisms and Treatment.
- Published in:
- Oncology & Therapy, 2021, v. 9, n. 2, p. 385, doi. 10.1007/s40487-021-00168-y
- By:
- Publication type:
- Article
An In-Depth Review of Niraparib in Ovarian Cancer: Mechanism of Action, Clinical Efficacy and Future Directions.
- Published in:
- Oncology & Therapy, 2021, v. 9, n. 2, p. 347, doi. 10.1007/s40487-021-00167-z
- By:
- Publication type:
- Article
Understanding the Patient Experience in NUT Carcinoma: Qualitative Interviews with Patients and Caregivers to Develop a Conceptual Framework.
- Published in:
- Oncology & Therapy, 2021, v. 9, n. 2, p. 591, doi. 10.1007/s40487-021-00166-0
- By:
- Publication type:
- Article
American Society of Clinical Oncology 2021 Podcast: HR+, HER2− Breast Cancer.
- Published in:
- Oncology & Therapy, 2021, v. 9, n. 2, p. 267, doi. 10.1007/s40487-021-00164-2
- By:
- Publication type:
- Article
What is the Definition of Cure in Non-small Cell Lung Cancer?
- Published in:
- Oncology & Therapy, 2021, v. 9, n. 2, p. 365, doi. 10.1007/s40487-021-00163-3
- By:
- Publication type:
- Article
A Real-World Evidence Study of CDK4/6 Inhibitor Treatment Patterns and Outcomes in Metastatic Breast Cancer by Germline BRCA Mutation Status.
- Published in:
- Oncology & Therapy, 2021, v. 9, n. 2, p. 575, doi. 10.1007/s40487-021-00162-4
- By:
- Publication type:
- Article
Early Relapse in First-Line Follicular Lymphoma: A Review of the Clinical Implications and Available Mitigation and Management Strategies.
- Published in:
- Oncology & Therapy, 2021, v. 9, n. 2, p. 329, doi. 10.1007/s40487-021-00161-5
- By:
- Publication type:
- Article
A Narrative Review of Implementing Precision Oncology in Metastatic Castration-Resistant Prostate Cancer in Emerging Countries.
- Published in:
- Oncology & Therapy, 2021, v. 9, n. 2, p. 311, doi. 10.1007/s40487-021-00160-6
- By:
- Publication type:
- Article
Understanding Patient Experience in Biliary Tract Cancer: A Qualitative Patient Interview Study.
- Published in:
- Oncology & Therapy, 2021, v. 9, n. 2, p. 557, doi. 10.1007/s40487-021-00159-z
- By:
- Publication type:
- Article
Validating TDP1 as an Inhibition Target for the Development of Chemosensitizers for Camptothecin-Based Chemotherapy Drugs.
- Published in:
- Oncology & Therapy, 2021, v. 9, n. 2, p. 541, doi. 10.1007/s40487-021-00158-0
- By:
- Publication type:
- Article
Emerging issues related to COVID-19 vaccination in patients with cancer.
- Published in:
- Oncology & Therapy, 2021, v. 9, n. 2, p. 255, doi. 10.1007/s40487-021-00157-1
- By:
- Publication type:
- Article
Evaluation of the Effect of Proton Pump Inhibitors on the Efficacy of Dacomitinib and Gefitinib in Patients with Advanced Non-Small Cell Lung Cancer and EGFR-Activating Mutations.
- Published in:
- Oncology & Therapy, 2021, v. 9, n. 2, p. 525, doi. 10.1007/s40487-021-00156-2
- By:
- Publication type:
- Article
Crizotinib Versus Conventional Chemotherapy in First-Line Treatment for ALK-Positive Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis.
- Published in:
- Oncology & Therapy, 2021, v. 9, n. 2, p. 505, doi. 10.1007/s40487-021-00155-3
- By:
- Publication type:
- Article
Clinical Management of Liver Cancer in India and Other Developing Nations: A Focus on Radiation Based Strategies.
- Published in:
- Oncology & Therapy, 2021, v. 9, n. 2, p. 273, doi. 10.1007/s40487-021-00154-4
- By:
- Publication type:
- Article
How to Optimise Extended Adjuvant Treatment with Neratinib for Patients with Early HER2+ Breast Cancer.
- Published in:
- Oncology & Therapy, 2021, v. 9, n. 2, p. 297, doi. 10.1007/s40487-021-00153-5
- By:
- Publication type:
- Article
A Real-World Analysis of Patients with Untreated Metastatic Epidermal Growth Factor Receptor (EGFR)-Mutated Lung Adenocarcinoma Receiving First-Line Erlotinib and Bevacizumab Combination Therapy.
- Published in:
- Oncology & Therapy, 2021, v. 9, n. 2, p. 489, doi. 10.1007/s40487-021-00152-6
- By:
- Publication type:
- Article
Recommendations for Specimen and Therapy Selection in Colorectal Cancer.
- Published in:
- Oncology & Therapy, 2021, v. 9, n. 2, p. 451, doi. 10.1007/s40487-021-00151-7
- By:
- Publication type:
- Article
Incidence and Risk Factors of Pneumonitis in Patients with Non-Small Cell Lung Cancer: An Observational Analysis of Real-World Data.
- Published in:
- Oncology & Therapy, 2021, v. 9, n. 2, p. 471, doi. 10.1007/s40487-021-00150-8
- By:
- Publication type:
- Article